Skip to content

A new patient zero? Researchers may have spotted animal-to-human immunodeficiency virus transfer

Sabrina Locatelli, presenting at CROI. (http://retroconference.org)

Lipoatrophy common in children receiving d4T in South Africa

Keeping mothers in care: the real-world challenge for PMTCT programmes

Lopinavir/ritonavir cuts malaria risk in children with HIV

Lopinavir/ritonavir cuts malaria risk in children with HIV

GS-7977 plus ribavirin rapidly suppresses HCV but most patients relapse

Presenter Edward Gane

Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected

Prof. Douglas Dieterich (left) and Prof. Mark Sulkowski (right).

Hormonal contraception and HIV risk in women: more evidence but uncertainty remains

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

Four doses of PrEP a week may be enough to protect

Detail from iPrEx materials (www.globaliprex.com).